1-2 of 2
Cristina Gil
Close
Sort by
Journal Articles

Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study

Clinical Trials & Observations
David Martínez-Cuadrón, Juan E. Megías-Vericat, Josefina Serrano, Pilar Martínez-Sánchez, Eduardo Rodríguez-Arbolí, Cristina Gil, Eliana Aguiar, Juan Bergua, José L. López-Lorenzo, Teresa Bernal, Ana Espadana, Mercedes Colorado, Carlos Rodríguez-Medina, María López-Pavía, Mar Tormo, Lorenzo Algarra, María-Luz Amigo, María J. Sayas, Jorge Labrador, Juan I. Rodríguez-Gutiérrez, Celina Benavente, Lissette Costilla-Barriga, Raimundo García-Boyero, Esperanza Lavilla-Rubira, Susana Vives, Pilar Herrera, Daniel García-Belmonte, María Mar Herráez, Graça Vasconcelos Esteves, Maria I. Gómez-Roncero, Ana Cabello, Guiomar Bautista, Amaia Balerdi, José Mariz, Blanca Boluda, Miguel Á. Sanz, Pau Montesinos
Journal: Blood Advances
Blood Adv (2022) 6 (4): 1278–1295.
https://doi.org/10.1182/bloodadvances.2021005335
Published: 2022
Includes: Supplemental data
Journal Articles

Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial

Clinical Trials & Observations
Catia Simoes, Bruno Paiva, David Martínez-Cuadrón, Juan-Miguel Bergua, Susana Vives, Lorenzo Algarra, Mar Tormo, Pilar Martinez, Josefina Serrano, Pilar Herrera, Fernando Ramos, Olga Salamero, Esperanza Lavilla, Cristina Gil, Jose-Luis Lopez, Maria-Belen Vidriales, Jorge Labrador, Jose-Francisco Falantes, María-José Sayas, Rosa Ayala, Joaquin Martinez-Lopez, Sara Villar, Maria-Jose Calasanz, Felipe Prosper, Jesús F. San-Miguel, Miguel Ángel Sanz, Pau Montesinos
Journal: Blood Advances
Blood Adv (2021) 5 (3): 760–770.
https://doi.org/10.1182/bloodadvances.2020003195
Published: 2021
Includes: Supplemental data